Phase I Study of Oral PQR309 in Patients With Advanced Solid Tumors
Latest Information Update: 20 Apr 2018
At a glance
- Drugs Bimiralisib (Primary)
- Indications Solid tumours
- Focus Adverse reactions; First in man
- Sponsors PIQUR Therapeutics
- 13 Apr 2018 Results published in the European Journal of Cancer
- 26 Sep 2016 Status changed from active, no longer recruiting to completed.
- 07 Jun 2016 Results (n=41) from this trial and other trial (NCT02483858) presented at the 52nd Annual Meeting of the American Society of Clinical Oncology